Across TCGA pan-cancer cohorts, BAIAP2-DT RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated BAIAP2-DT data layer.
The strongest signal is observed in breast invasive carcinoma (BRCA), where higher BAIAP2-DT RNA is associated with better overall survival. In most high-consensus cancer types, elevated BAIAP2-DT expression acts as an unfavorable survival marker, although some lineages such as BRCA and UVM show a favorable association.
BRCA, UVM, and HNSC are the cancer types where BAIAP2-DT RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.